The Impact of Risk Information on Patients' Willingness to Pay for Autologous Blood Donation

Medical Care

Volumn 36, Issue 8, 1998, Pages 1162-1173

  Lee, Stephanie J ^a,e   Liljas, Bengt ^c   Neumann, Peter J ^b   Weinstein, Milton C ^b   Johannesson, Magnus ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c LUND UNIVERSITY   (Sweden)

^d STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Blood transfusion; Contingent valuation; Cost benefit; Cost effectiveness; Information; Risks; Willingness to pay

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BLOOD AUTOTRANSFUSION; CLINICAL TRIAL; ECONOMICS; FEAR; FEMALE; FINANCIAL MANAGEMENT; HUMAN; INCOME; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT ATTITUDE; PATIENT EDUCATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL MODEL; UNITED STATES;

ADULT; AGED; BLOOD TRANSFUSION, AUTOLOGOUS; FEAR; FEMALE; FINANCING, PERSONAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INCOME; LOGISTIC MODELS; MAINE; MALE; MASSACHUSETTS; MIDDLE AGED; MODELS, ECONOMETRIC; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; QUESTIONNAIRES; RISK FACTORS;

EID: 0032133228     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199808000-00005     Document Type: Article

References (42)

1. Rutherford CJ, Kaplan HS. Autologous blood donation - can we bank on it? N Engl J Med 1995;332:740.
2. Council on Scientific Affairs. Autologous blood transfusions. JAMA 1986;256:2378.
3. American College of Physicians. Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992;116:403.
4. Toy PTCY, Strauss RG, Stehling LC, et al. Predeposited autologous blood for elective surgery. N Engl J Med 1987;316:517.
5. Kruskall MS, Yomtovian R, Dzik WH, Friedman KD, Umlas J. On improving the cost-effectiveness of autologous blood transfusion practices. Transfusion 1994;34:259.
6. The National Blood Resource Education Program Expert Panel. The use of autologous blood. JAMA 1990;263:414.
7. Yomtovian R, Kruskall MS, Barber JP. Autologous-blood transfusion: The reimbursement dilemma. J Bone Joint Surg 1992;74:1265.
8. State of California. Paul Gann Blood Safety Act. Health and Safety Code, Section 1645, January 1, 1990.
9. Etchason J, Petz L, Keeler E, et al. The cost-effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332:719.
10. Birkmeyer JD, AuBuchon JP, Littenberg B, et al. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg 1994;57:161.
11. Renner SW, Howanitz PJ, Bachner P. Preoperative autologous blood donation in 612 hospitals. A college of American Pathologists' Q-Probes study of quality issues in transfusion practice. Arch Pathol Lab Med 1992;116:613.
12. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions. Infectious disease testing for blood transfusions. JAMA 1995;274:1374.
13. AuBuchon JP, Birkmeyer JD. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Transfusion 1994;34:79.
14. Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 1993;33:544.
15. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721.
16. US Public Health Service. Guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen. MMWR Morb Mortal Wkly Rep 1996;45:1.
17. Forbes JM, Laurie ML. Blood collections by community blood centers, 1988 through 1992. Transfusion 1994;34:392.
18. Wallace EL, Surgenor DM, Hao HS, An J, Chapman RH, Churchill WH. Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993;33:139.
19. Surgenor DM, Wallace EL, Hao SHS, Chapman RH. Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 1990;322:1646.
20. Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995;35:802.
21. American Association of Blood Banks. Attitudes of US adults toward AIDS and the safety of America's blood supply. 1993 Gallup Survey.
22. Lee SJ, Neumann PJ, Churchill WH, Cannon ME, Weinstein MC, Johannesson M. Patients' willingness to pay for autologous blood donation. Health Policy 1997;40:1.
23. Johansson P-O. Evaluating health risks. An economic approach. Cambridge: Cambridge University Press, 1996.
24. Eastaugh SR. Valuation of the benefits of risk-free blood. Willingness to pay for hemoglobin solutions. Int J Tech Assess Health Care 1991;7:51.
25. Viscusi KW. Prospective reference theory: Toward an explanation of the paradoxes. J Risk Uncertainty 1989;2:235.
26. Viscusi KW. Fatal tradeoffs: Public and private responsibilities for risk. New York: Oxford University Press, 1992.
27. Smith VK. Environmental risk perception and valuation: Conventional versus prospective reference theory. In: Bromley DW, Segerson K, eds. The social response to environmental risk: Policy formulation in an age of uncertainty. Dordrecht: Kluwer Academic Publishers, 1992.
28. Viscusi KW, O'Connor CJ. Adaptive responses to chemical labeling: Are workers Bayesian decision makers? Am Econ Rev 1984;74:942.
29. Smith VK, Johnson RF. How do risk perceptions respond to information?: The case of radon. Rev Econ Stat 1988;70:1.
30. Smith VK, Desvousges W, Johnson RF, Fisher A. Can public information programs affect risk perceptions? J Pol Man 1990;9:41.
31. Mitchell RC, Carson RT. Using surveys to value public goods: The contingent valuation method. 1st ed. Washington DC: Resources for the Future, 1989.
32. Kriström B. A nonparametric approach to the estimation of welfare measures in discrete response valuation studies. Land Economics 1990;66:135.
33. Hanemann MW. Welfare evaluations in contingent valuation experiments with discrete responses. Am J Agricult Econ 1984;66:332.
34. Gafni A. Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decision-making about health care programs. Med Care 1991;29:1246.
35. National Oceanic and Atmospheric Administration. Report of the NOAA panel on contingent valuation. Federal Register 1993;58:4602.
36. Donahue JG, Munoz A, Ness PM, et al. The declining risk of posttransfusion hepatitis C virus infection. N Engl J Med 1992;327:369.
37. Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion 1992;32:601.
38. National Safety Council. Accident Facts. Itasca, IL: National Safety Council. 1994.
39. Cameron TA. A new paradigm for valuing non-market goods using referendum data: Maximum likelihood estimation by censored logistic regression. J Environ Econom Management 1988;3:355.
40. Greene WH. Econometric Analysis. 2nd ed. New York: Macmillan, 1993.
41. Slovic P. Perception of risk. Science 1987; 236:280.
42. Johannesson M. A note on the relationship between ex ante and expected willingness to pay for health care. Soc Sci Med 1996;42:305.